Search

Search Results

• Rilzabrutinib-induced transition from pemphigus vulgaris to pemphigus foliaceous: a case report and literature review

  Christian Ciolfi, Jacopo Tartaglia, Francesca Pampaloni, Laura Fagotto, Andrea Sechi, Mauro Alaibac

  23-10-2024

  https://doi.org/10.4081/dr.2024.10010

  663

  PDF: 391

  SUPPLEMENTARY MATERIAL: 177

  HTML: 34
• 

  Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

  Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  19-05-2023

  https://doi.org/10.4081/dr.2023.9692

  1143

  PDF: 567

  HTML: 25
• 

  Pityriasis rosea and pityriasis rosea-like eruption after anti-SARS-CoV-2 vaccination: a report of five cases and review of the literature

  Stefano Veraldi, Vinicio Boneschi, Marco Cusini, Carlo Alberto Maronese

  06-07-2022

  https://doi.org/10.4081/dr.2022.9503

  1388

  PDF: 486

  HTML: 94
• 

  Effects of canary seed on two patients with disseminated granuloma annulare

  Lily Park, Claudia Green, Sergey Arutyunyan, Gabriella Vasile, Christopher Buckley, Eduardo Weiss

  23-12-2022

  https://doi.org/10.4081/dr.2023.9614

  1623

  PDF: 562

  HTML: 520
• 

  Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review

  Alexandra Maria Giovanna Brunasso, Sanja Javor, Emanuele Pontali, Simona Sola, Cesare Massone

  29-07-2021

  https://doi.org/10.4081/dr.2021.8797

  3126

  PDF: 663

  HTML: 16
• 

  Environmental factors in autoimmune bullous diseases with a focus on seasonality: new insights

  Roberto D'Astolto, Lavinia Quintarelli, Alberto Corrà, Marzia Caproni, Luca Fania, Giovanni Di Zenzo, Biagio Didona, Giulia Gasparini, Emanuele Cozzani, Claudio Feliciani

  14-06-2023

  https://doi.org/10.4081/dr.2023.9641

  1042

  PDF: 507

  HTML: 30

• Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

  Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

  11-11-2024

  https://doi.org/10.4081/dr.2024.10140

  1051

  PDF: 566

  SUPPLEMENTARY MATERIAL: 180

  HTML: 20
• 

  Erythrodermic psoriasis improved by tildrakizumab

  Giampaolo Trevisan, Lerica Germi, Luigi Naldi

  23-11-2022

  https://doi.org/10.4081/dr.2022.9448

  1309

  PDF: 636

  HTML: 26

• Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

  Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi

  13-09-2023

  https://doi.org/10.4081/dr.2023.9839

  2827

  PDF: 1005

  HTML: 35
• 

  Ustekinumab in the treatment of acute disseminated pyoderma gangrenosum in a patient with Crohn’s disease

  Klaudia Miklusiak, Karol Miklusiak, Olga Kaczmarczyk, Dorota Cibor, Małgorzata Zwolińska-Wcisło

  22-05-2023

  https://doi.org/10.4081/dr.2023.9630

  1104

  PDF: 586

  HTML: 87

• The efficacy of apremilast in pemphigus: a systematic review of case reports

  Roudin H. Alhasawi, Esraa A. Shaheen, Noura M. Alshabanat, Reem Brashi, Walaa Abdu Ahmed, Shumukh H. Alqahtani, Ethar G. Alharbi, Mazin Aljabri

  07-05-2025

  https://doi.org/10.4081/dr.2025.10245

  997

  PDF: 445

  SUPPLEMENTARY MATERIAL: 59

  HTML: 15
• 

  Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

  Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen

  11-10-2017

  https://doi.org/10.4081/dr.2017.7079

  1417

  PDF: 679

  HTML: 146
• 

  Exploring valrubicin’s effect on Propionibacterium acnes-induced skin inflammation in vitro and in vivo

  Louise Rottboell, Sarah de Foenss, Kenneth Thomsen, Helle Christiansen, Stine M. Andersen, Thomas N. Dam, Cecilia Rosada, Karin Stenderup

  17-12-2015

  https://doi.org/10.4081/dr.2015.6246

  3211

  PDF: 970

  HTML: 763

• Genetic variations in the ST18 gene and their association with pemphigus vulgaris in Vietnamese patients: insights from a case series

  Thi Xuan Tam Huynh, Long Phan Son

  22-04-2025

  https://doi.org/10.4081/dr.2025.10265

  457

  PDF: 269

  HTML: 12

• Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

  Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

  12-11-2024

  https://doi.org/10.4081/dr.2024.10080

  1317

  PDF: 726

  HTML: 38

• New and emerging therapies in cutaneous T-cell lymphoma

  Gabriele Roccuzzo, Nicole Macagno, Silvia Giordano, Paolo Fava, Pietro Quaglino

  02-10-2024

  https://doi.org/10.4081/dr.2024.10002

  1167

  PDF: 659

  HTML: 105
• 

  Evaluation of the glycemic effect of methotrexate in psoriatic arthritis patients with metabolic syndrome: A pilot study

  Tannaz Dehpouri, Ghasem Rahmatpour Rokni, Nematollah Ahangar Narenjbon, Mohamad Goldust, Paul S. Yamauchi, Uwe Wollina, Torello Lotti, Leon Kircik, Vito Giuseppe Di Lernia, Sidharth Sonthalia, Aleksandra Vojvodic, Jacek Szepietowski, Philippe Bahadoran, Enzo Errichetti, Carmen Cantisani, Laura Atzori, Elham Rezaee, Zekayi Kutlubay, Burhan Engin, Steven Nisticò, Giovanni Damiani, Rosalynn R.Z. Conic, Andy Goren, Leo Čabrijan, Georgi Tchernev

  09-05-2019

  https://doi.org/10.4081/dr.2019.7965

  2582

  PDF: 976

  HTML: 927
• 

  Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

  Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero

  17-03-2022

  https://doi.org/10.4081/dr.2022.9282

  1191

  PDF: 854

  HTML: 46
• 

  Progress in psoriasis therapy via novel drug delivery systems

  Nitha Vincent, Ramya Devi D, Vedha Hari BN

  08-09-2014

  https://doi.org/10.4081/dr.2014.5451

  3832

  PDF: 2210

  HTML: 703
• 

  Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

  Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi

  29-12-2022

  https://doi.org/10.4081/dr.2023.9613

  1810

  PDF: 558

  HTML: 93
• 

  Metastatic basal cell carcinoma to the bone: a case of bone metastasis in uncommon sites

  Olga Nigro, Claudio Chini, Ilaria Gioia Angiola Marcon, Annamaria De Giorgi, Linda Bascialla, Elisa Gallerani, Alice Giaquinto, Diego De Palma, Maurizio Lombardo

  12-07-2022

  https://doi.org/10.4081/dr.2022.9267

  1095

  PDF: 523

  Supplementary Table: 244

  HTML: 19

• Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

  Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo

  30-05-2025

  https://doi.org/10.4081/dr.2025.10414

  814

  PDF: 451

  HTML: 33
• 

  Epidermolysis bullosa acquisita: current diagnosis and therapy

  Christine R. Mehren, Robert Gniadecki

  e38

  28-11-2011

  https://doi.org/10.4081/dr.2011.e38

  1611

  PDF: 908

  HTML: 130

• Heparin-induced thrombocytopenia: a rare presentation with skin necrosis

  Filipa David, Ana Catarina Trigo, José Ribeiro, Joana Cancela

  16-10-2023

  https://doi.org/10.4081/dr.2023.9855

  828

  PDF: 491

  HTML: 22
• 

  Post-inflammatory hyperpigmentation after carbon dioxide laser: review of prevention and risk factors

  Alhanouf Bin Dakhil, Asem Shadid, Saad Altalhab

  19-05-2023

  https://doi.org/10.4081/dr.2023.9703

  6067

  PDF: 964

  APPENDIX 1: 159

  HTML: 188